172 related articles for article (PubMed ID: 35200623)
1. Biological Activity and Stability of Aeruginosamides from Cyanobacteria.
Cegłowska M; Kwiecień P; Szubert K; Brzuzan P; Florczyk M; Edwards C; Kosakowska A; Mazur-Marzec H
Mar Drugs; 2022 Jan; 20(2):. PubMed ID: 35200623
[TBL] [Abstract][Full Text] [Related]
2. Eighteen New Aeruginosamide Variants Produced by the Baltic Cyanobacterium
Cegłowska M; Szubert K; Wieczerzak E; Kosakowska A; Mazur-Marzec H
Mar Drugs; 2020 Aug; 18(9):. PubMed ID: 32867236
[TBL] [Abstract][Full Text] [Related]
3. Trichormamides C and D, antiproliferative cyclic lipopeptides from the cultured freshwater cyanobacterium cf. Oscillatoria sp. UIC 10045.
Luo S; Kang HS; Krunic A; Chen WL; Yang J; Woodard JL; Fuchs JR; Hyun Cho S; Franzblau SG; Swanson SM; Orjala J
Bioorg Med Chem; 2015 Jul; 23(13):3153-62. PubMed ID: 26001342
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and peptidase inhibitory activities of selected non-hepatotoxic cyclic peptides from cyanobacteria.
Bubik A; Sedmak B; Novinec M; Lenarcic B; Lah TT
Biol Chem; 2008 Oct; 389(10):1339-46. PubMed ID: 18713022
[TBL] [Abstract][Full Text] [Related]
5. Phytoplankton of the Curonian Lagoon as a New Interesting Source for Bioactive Natural Products. Special Impact on Cyanobacterial Metabolites.
Overlingė D; Toruńska-Sitarz A; Cegłowska M; Błaszczyk A; Szubert K; Pilkaitytė R; Mazur-Marzec H
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439804
[TBL] [Abstract][Full Text] [Related]
6. Microcyclamide, a cytotoxic cyclic hexapeptide from the cyanobacterium Microcystis aeruginosa.
Ishida K; Nakagawa H; Murakami M
J Nat Prod; 2000 Sep; 63(9):1315-7. PubMed ID: 11000050
[TBL] [Abstract][Full Text] [Related]
7. The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions.
Danek PJ; Wójcikowski J; Daniel WA
Pharmacol Rep; 2020 Dec; 72(6):1685-1694. PubMed ID: 32279279
[TBL] [Abstract][Full Text] [Related]
8. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
[TBL] [Abstract][Full Text] [Related]
9. Trikoramides B-D, Bioactive Cyanobactins from the Marine Cyanobacterium
Phyo MY; Goh TMB; Goh JX; Tan LT
Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677447
[TBL] [Abstract][Full Text] [Related]
10. Ulongapeptin, a cytotoxic cyclic depsipeptide from a Palauan marine cyanobacterium Lyngbya sp.
Williams PG; Yoshida WY; Quon MK; Moore RE; Paul VJ
J Nat Prod; 2003 May; 66(5):651-4. PubMed ID: 12762800
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity and cytochrome P450 inhibitory activities of Clinacanthus nutans.
Quah SY; Chin JH; Akowuah GA; Khalivulla SI; Yeong SW; Sabu MC
Drug Metab Pers Ther; 2017 Mar; 32(1):59-65. PubMed ID: 28253196
[TBL] [Abstract][Full Text] [Related]
12. Tutuilamides A-C: Vinyl-Chloride-Containing Cyclodepsipeptides from Marine Cyanobacteria with Potent Elastase Inhibitory Properties.
Keller L; Canuto KM; Liu C; Suzuki BM; Almaliti J; Sikandar A; Naman CB; Glukhov E; Luo D; Duggan BM; Luesch H; Koehnke J; O'Donoghue AJ; Gerwick WH
ACS Chem Biol; 2020 Mar; 15(3):751-757. PubMed ID: 31935054
[TBL] [Abstract][Full Text] [Related]
13. Isolation of homodolastatin 16, a new cyclic depsipeptide from a Kenyan collection of Lyngbya majuscula.
Davies-Coleman MT; Dzeha TM; Gray CA; Hess S; Pannell LK; Hendricks DT; Arendse CE
J Nat Prod; 2003 May; 66(5):712-5. PubMed ID: 12762816
[TBL] [Abstract][Full Text] [Related]
14. N-Methylsansalvamide, a cytotoxic cyclic depsipeptide from a marine fungus of the genus fusarium.
Cueto M; Jensen PR; Fenical W
Phytochemistry; 2000 Oct; 55(3):223-6. PubMed ID: 11142846
[TBL] [Abstract][Full Text] [Related]
15. Cyanobactins-ribosomal cyclic peptides produced by cyanobacteria.
Sivonen K; Leikoski N; Fewer DP; Jokela J
Appl Microbiol Biotechnol; 2010 May; 86(5):1213-25. PubMed ID: 20195859
[TBL] [Abstract][Full Text] [Related]
16. Dendroamides, new cyclic hexapeptides from a blue-green alga. Multidrug-resistance reversing activity of dendroamide A.
Ogino J; Moore RE; Patterson GM; Smith CD
J Nat Prod; 1996 Jun; 59(6):581-6. PubMed ID: 8786364
[TBL] [Abstract][Full Text] [Related]
17. Tasipeptins A and B: new cytotoxic depsipeptides from the marine cyanobacterium Symploca sp.
Williams PG; Yoshida WY; Moore RE; Paul VJ
J Nat Prod; 2003 May; 66(5):620-4. PubMed ID: 12762794
[TBL] [Abstract][Full Text] [Related]
18. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Formation of descarboethoxyloratadine by CYP3A4 and CYP2D6.
Yumibe N; Huie K; Chen KJ; Snow M; Clement RP; Cayen MN
Biochem Pharmacol; 1996 Jan; 51(2):165-72. PubMed ID: 8615885
[TBL] [Abstract][Full Text] [Related]
19. Development of a method to determine cytochrome P450 1A2, 2C9, 2D6 and 3A4 activity sheep hepatic microsomes.
McBride GM; Soo JY; Varcoe T; Morrison JL; Wiese MD
J Pharmacol Toxicol Methods; 2020; 106():106934. PubMed ID: 33080390
[TBL] [Abstract][Full Text] [Related]
20. Isolation and structure assignments of rostratins A-D, cytotoxic disulfides produced by the marine-derived fungus Exserohilum rostratum.
Tan RX; Jensen PR; Williams PG; Fenical W
J Nat Prod; 2004 Aug; 67(8):1374-82. PubMed ID: 15332857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
